All lobbying filings

MILLER STRATEGIES, LLC

Lobbying for AMGEN, INC. · biopharmaceutical company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · $60,000.00 income · posted Apr 20, 2026

Official filing document

Bills named in this filing 1

HR 3517
Social Security Enhancement and Protection Act of 2025

Lobbying activity 3

Health Issues

Healthcare policy issues as they relate to the pharmaceutical industry including drug pricing and biosimilars

Medicare/Medicaid

Issues related to drug pricing, biosimilars, Medicare Part D and Medicare Part B; H.R. 3517 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021

Immigration

Issues related to visas

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.